Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1

Yanan Yang(Shanghai Medical College of Fudan University), Weijian Guo(Shanghai Medical College of Fudan University), Chenchen Wang(Shanghai Medical College of Fudan University), Jin Li(Shanghai East Hospital), Xinyang Liu(University of Macau), Xiaoying Zhao(Handan College), Mingzhu Huang(Fudan University Shanghai Cancer Center), Dongmei Ji(Fudan University Shanghai Cancer Center), Congqi Dai(Fudan University Shanghai Cancer Center), Wenhua Li(University of Hong Kong)
Acta Biochimica et Biophysica Sinica
March 1, 2021
10.1093/abbs/gmab026
Cited by 21

Related Papers

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|247
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
|Journal of Clinical Investigation|2011|197